The Oncology Unit at SJD Barcelona Children's Hospital stabilises a high-grade glioma thanks to targeted therapies

by Fundació Sant Joan de Déu

The joint work of the healthcare and research team, together with a precise diagnosis from the molecular biology laboratory and the surgical team's work made it possible to treat a patient who had run...

Read more

ORYZON publishes paper in ACS Pharmacology & Translational Science supporting best-in-class performance of iadademstat in Oncology

by Oryzon Genomics

The manuscript, entitled "Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology”, compares iadademstat with four LSD1 inhibitors in clinical development in o...

Read more

An indicator of endothelial dysfunction predicts the need for ICU transfer in patients with bone marrow transplantation

by Hospital Universitari de Bellvitge

Bone marrow transplantation can be a curative therapy for those patients with malignant and non-malignant hematological diseases. However, such treatment may cause life-threatening complications and h...

Read more

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

by CAS, a division of the American Chemical Society

New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...

Read more

The Gregory Foundation For Cancer Research Strengthens Their Commitment By Investing Again In Oncoheroes Biosciences

by Oncoheroes Biosciences

“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...

Read more

Avoiding Costly IP Missteps: Insights for high-quality due diligence searches

by CAS, a division of the American Chemical Society

As chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...

Read more

Challenges in manufacturing high value lyophilized oncology drugs

by Telstar

A complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-...

Read more

OncoDNA announces expansion of its services into the United States

by OncoDNA

The theranostic and genomic company signs subcontract service agreement with HalioDx’s CLIA-certified laboratory in Richmond, Virginia

Read more

ORYZON Reports Results for Quarter Ended September 30, 2020 and Provides Corporate Update

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...

Read more

American Hospital of Paris and OncoDNA Partner to Advance Breast Cancer Patients Management

by OncoDNA

American Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...

Read more

EuCanImage: Next-generation artificial intelligence in oncology

by Fundació Bosch i Gimpera

EuCanImage has been launched. This project from the Horizon 2020 program is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science of t...

Read more

Maximizing the oncology production process

by Telstar

Telstar’s cutting-edge technologies and integrated process equipment & systems covering all the critical phases of the oncology production are designed according to the higher requirements of qualit...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Young Adults with Higher Exposure to Hou...

by ISGlobal - Instituto de Salud Global de Barcelona

A study conducted in South India adds new evidence on the detrimental ...

Photos Stream